The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global ...

It has been several decades since a new class of antibiotics hit the market. However, findings published in a medical journal in March, showcase a breakthrough discovery that could add another ...

Its approval is a rare example of a new class of antibiotic reaching the market at a time when there is growing concern about the rising tide of antimicrobial resistance (AMR), which already kills ...

The global veterinary antibiotics market is on a strong growth trajectory, anticipated to reach approximately USD 12,820.4 million by 2025 and further expand to an impressive USD 22,559.7 million by ...

The Global Antimicrobial Additives Market was valued at approximately USD 4.92 billion in 2023 and is expected to grow with a healthy growth rate of more than 7.04% over the forecast period 2024-2032.

Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to the US market – 13 years after its first attempt was turned down – thanks to a new phase 3 clinical trial.

Aquaculture Therapeutics Market Aquaculture Therapeutics Market Forecast 2025-2035: Trends, Growth Drivers, and Opportunities Shaping the I ...

The Pediatric Antibiotics Market comprises specialized formulations of beta-lactams, macrolides, cephalosporins, and sulfonamides designed to treat bacterial infections in infants and children. These ...

The antimicrobial peptides market is experiencing significant growth, driven by the rising prevalence of antibiotic-resistant infections and the demand for novel antimicrobial therapies.

Explore the booming antimicrobial peptides market, projected to grow from $6.49 billion in 2024 to $9.63 billion in 2029 at an 8.2% CAGR. Driven by a ...